Status:
COMPLETED
Trial of Autologous Mesenchymal Stem Cells in Patients With Multiple System Atrophy
Lead Sponsor:
Yonsei University
Conditions:
Multiple System Atrophy
Eligibility:
All Genders
Up to 75 years
Phase:
PHASE2
Brief Summary
This study is based on positive results in open label trial of mesenchymal stem cells therapy in patients with Multiple System Atrophy (MSA).
Eligibility Criteria
Inclusion
- 75 Years Old or Less
- Multiple System Atrophy
- Voluntary Participants
Exclusion
- Doubted dementia (MMSE \< 24)
- Severe febrile condition
- Serum SGOT/SGPT three times above
- Malignant mass
Key Trial Info
Start Date :
May 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2011
Estimated Enrollment :
27 Patients enrolled
Trial Details
Trial ID
NCT00911365
Start Date
May 1 2008
End Date
June 1 2011
Last Update
August 4 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Severance Hospital
Seoul, South Korea, 120752